Delivery Order SPE2D021DA002-SPE2D325F0925

Award Date 10/28/24
Potential Completion Date 10/29/24
Potential Value $5.9K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $5,905.20, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award is a firm fixed-price delivery order for the supply of ENGERIX-B 20 MCG/ML SYRN, a pharmaceutical product, with an ultimate completion date of October 29, 2024. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 with...
This federal contract award, valued at $1,968.40, was issued by the Defense agency's Medical Supply Chain to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of Engerix-B 20 MCG/ML SYRN, a pharmaceutical product, with a completion date of April 11, 2024. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract, valued at up to $4,999,999, with the Defense Logistics Agency under the SPE2DB program. This...
This is a federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, by the Defense Logistics Agency (DLA). The $10,912.32 firm fixed-price delivery order is for the supply of ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This IDC allows the DLA to issue delivery orders for a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,603.16 firm fixed-price delivery order is for the supply of ENGERIX-B 20 MCG/ML SYRNML, a hepatitis B vaccine, with no set-aside designation. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the...
This federal contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business. The $5,596.65 firm fixed price delivery order is for the pharmaceutical product ENGERIX-B 20 MCG/ML SYRN. DMS Pharmaceutical Group holds various contracts and indefinite delivery vehicles (IDVs) with DLA to provide pharmaceuticals and medical supplies to support military treatment facilities worldwide. This delivery order is...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract award, valued at $5,636.55, is for the supply of ENGERIX-B 20 MCG/ML SYRNML, a pharmaceutical product. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This IDC...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is for the delivery of ENGERIX-B 20 MCG/ML SYRN pharmaceutical items to the Defense Logistics Agency (DLA) Troop Support Medical. The firm fixed price delivery order, valued at $1,865.55, was awarded on May 16, 2022 and is set to be completed by May 17, 2022. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that holds various federal contracts and Indefinite Delivery Vehicles (IDVs) to...
This federal contract award, valued at $81,657.37, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order under the DLA's SPE2DB Indefinite Delivery Contract (IDC), which has a total potential value of $499,999,999 and expires in November 2026. Through this contract, DMS Pharmaceutical Group will provide a comprehensive range of...
This is a $1,969.50 firm fixed-price delivery order contract awarded to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract is for the provision of ENGERIX-B 20 MCG/ML SYRNML, a pharmaceutical product, to the Defense Logistics Agency (DLA), the funding agency. The contract has an ultimate completion date of May 30, 2025 and was awarded on May 27, 2025. DMS Pharmaceutical Group Inc. is an experienced federal contractor, holding a significant...
This federal contract award, valued at $78,466.60, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order under the DLA's SPE2DB Indefinite Delivery Contract (IDC), which has a total potential value of $499,999,999 and is valid through November 2026. This award supports the DLA's pharmaceutical supply needs, enabling DMS...
  • SPE2D021DA002
    Indefinite Delivery Contract
  • SPE2D021DA002-SPE2D325F0925
    Delivery Order

This federal contract award, valued at $5,905.20, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of ENGERIX-B 20 MCG/ML SYRN, a pharmaceutical product.

DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. The contract covers an extensive portfolio of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables.

The contract does not have a set-aside designation, allowing DMS Pharmaceutical Group Inc. to leverage its status as a woman-owned small business to secure direct federal awards across multiple product categories and medical domains. This latest award is part of the company's ongoing efforts to serve as a crucial supplier in the federal pharmaceutical supply chain and provide direct distribution of prescription drugs and pharmacy services to Department of Defense healthcare sites.

Generated 1/27/25, 1:10 PM